Search Result "second cancer."
A Critical Review of Second-Generation Anti-EGFR Monoclonal Antibodies in Metastatic Colorectal Cancer
Journal: Current Drug Targets
Volume: 22 Issue: 9 Year: 2021 Page: 1034-1042
Author(s): Daniel Sur,Andrei Havasi,Alecsandra Gorzo,Claudia Burz
Darolutamide as a Second-Generation Androgen Receptor Inhibitor in the Treatment of Prostate Cancer
Journal: Current Molecular Medicine
Volume: 21 Issue: 4 Year: 2021 Page: 332-346
Author(s): Ali Abbasi,Ahmad Movahedpour,Ahmad Amiri,Mohamad Samare Najaf,Zohreh Mostafavi-Pour
What Else in Gemcitabine-Pretreated Advanced Pancreatic Cancer? An Update of Second Line Therapies
Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 1 Year: 2010 Page: 43-56
Author(s): Fausto Petrelli, Karen Borgonovo, Mara Ghilardi, Mary Cabiddu, Sandro Barni
WITHDRAWN: Second Cancer after Breast Cancer in Men
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 0 Year: 2022 Page: 1-1
Author(s):
The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 58-60
Author(s): Steven Tucker
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: A Systematic Review and NetworkMeta-analysis
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 9 Year: 2023 Page: 718-730
Author(s):
Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy
Journal: Current Clinical Pharmacology
Volume: 13 Issue: 2 Year: 2018 Page: 76-84
Author(s): Cesare Gridelli,Paolo Antonio Ascierto,Francesco Grossi,Editta Baldini,Adolfo Favaretto,Maria Chiara Garassino,Alessandro Morabito,Maria Rita Migliorino,Antonio Rossi,Filippo de Marinis
Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis
Journal: Reviews on Recent Clinical Trials
Volume: 10 Issue: 2 Year: 2015 Page: 142-145
Author(s): Paola Bertocchi,Chiara Abeni,Fausto Meriggi,Luigina Rota,Anna Rizzi,Brunella Di Biasi,Francesca Aroldi,Chiara Ogliosi,Giordano Savelli,Edoardo Rosso,Alberto Zaniboni
Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2011 Page: 296-306
Author(s): Jawaher Ansari, Syed A Hussain, Abdulla Alhasso, Rana Mahmood, Asif Ansari, John Glaholm
Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomibin Four Different Breast Cancer Cell Lines
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 16 Year: 2022 Page: 2909-2918
Author(s): Ergul Mutlu Altundag,Ayse Mine Yilmaz,Betul Karademir Yilmaz